Brenus Pharma
Develops an off-the-shelf in vivo immunotherapy platform for solid tumors
€11MSeries A
Role not disclosedLoading investors…
Activity from announced rounds
Develops an off-the-shelf in vivo immunotherapy platform for solid tumors
Develops small-molecule therapies for targeted protein degradation at the point of synthesis